Avui, dilluns 8 de juny, el Dipòsit Digital no estarà operatiu de 15:00 a 17:00 h per tasques de manteniment. Disculpeu les molèsties.
Hoy, lunes 8 de junio, el Dipòsit Digital no estará operativo de 15:00 a 17:00 h debido a tareas de mantenimiento. Disculpen las molestias.
Today, Monday, Jun 8th, the Digital Repository will be unavailable due to a system update.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by-nc-nd (c) Elsevier B.V., 2025
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/227049

Colistin-loaded biodegradable nanoparticles as a promising antibacterial medication to reduce colistin-induced toxicity

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Infectious diseases cause mortality rates over 17 million people per year. Among them, bacterial infections constitute one of the major causes. Pneumonia and nosocomial infections are the most severe bacterial infections. Moreover, the indiscriminate use of antibiotics during the last decades has triggered an increasing multiple resistance towards these drugs, which represents a serious global socioeconomic and public health risk. In this sense, nanomedicine has provided an innovative therapeutic alternative able to accumulate the drug in the site of the infection, improve its effectiveness and reduce the inherent toxicity, thus leading to overcoming bacterial resistance. In this work, we aimed to encapsulate colistin, an antibiotic commonly used against multi-drug resistant bacteria in polymeric nanoparticles of poly(lactic-co-glycolic) acid (COL-NPs). COL-NPs were optimized obtaining an average size below 200 nm, monodisperse population and a negative surface charge. Physicochemical assays confirmed that the drug was encapsulated into the polymeric matrix and COL-NPs possessed a round shape and a smooth surface. Moreover, COL-NPs were able to release the drug in a sustained manner and showed suitable stability. In addition, in vitro assays confirmed that COL-NPs were effective against different gram-negative bacterial species such as Pseudomonas aeruginosa, Escherichia coli and Acinetobacter baumannii. Finally, in vivo experiments showed that COL-NPs did not promote any toxicological effects in treated mice, reducing renal concentrations compared to the free drug, maintaining urea levels comparable to those of the control group, and decreasing most of the colistin-induced neurotoxic effects. All these results together suggest that COL-NPs could be a promising therapeutic tool against drug-resistant bacterial infections.

Citation

Citation

CANO FERNÁNDEZ, Amanda, et al. Colistin-loaded biodegradable nanoparticles as a promising antibacterial medication to reduce colistin-induced toxicity. International Journal of Pharmaceutics. 2025. Vol. 683. ISSN 0378-5173. [consulted: 8 of June of 2026]. Available at: https://hdl.handle.net/2445/227049

Export metadata

JSON - METS

Share record